SANDRA O'DONNELL: Open Payments
NPI 1548223266 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,312 in 60 payments from 13 companies in 2025. Trend: 2023 $1,959 · 2024 $1,533 · 2025 $2,312
Food & beverage: $2,312
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 9 | $644 |
| Arcutis Biotherapeutics, Inc. | 9 | $386 |
| ABBVIE INC. | 16 | $361 |
| Amgen Inc. | 6 | $191 |
| LEO Pharma Inc. | 6 | $169 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $155 |
| Lilly USA, LLC | 5 | $145 |
| Novartis Pharmaceuticals Corporation | 1 | $67 |
| Incyte Corporation | 2 | $58 |
| PFIZER INC. | 2 | $48 |
Products named: NEMLUVIO, Zoryve, SKYRIZI, OTEZLA, ILUMYA, TALTZ, ADBRY, ANZUPGO.
Industry payments across CA — which companies pay providers there.
